-
FRANK J. MACRI
Ophthalmology Branch, National Institute of Neurological Diseases and Blindness, and Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Public Health Service, United States Department of Health, Education and Welfare, Bethesda, Md.; Ophthalmology Branch, National Institute of Neurological Diseases and Blindness
-
ROBERT L. DIXON
Ophthalmology Branch, National Institute of Neurological Diseases and Blindness, and Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Public Health Service, United States Department of Health, Education and Welfare, Bethesda, Md.; Laboratory of chemical Pharmacology, National Cancer Institute
-
DAVID P. RALL
Ophthalmology Branch, National Institute of Neurological Diseases and Blindness, and Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Public Health Service, United States Department of Health, Education and Welfare, Bethesda, Md.; Laboratory of chemical Pharmacology, National Cancer Institute